The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kanner D.Yu.

Oncology Hospital No. 62, Moscow, Russia

Kononec P.V.

Oncology Hospital No. 62, Moscow, Russia

Shveikin A.O.

Moscow City Cancer Hospital No. 62 of Moscow Healthcare Department, Moscow, Russia

Shestakov A.L.

B.V. Petrovsky National Research Centre of Surgery, Moscow

Gastrointestinal stromal tumors: surgical treatment and targeted therapy

Authors:

Kanner D.Yu., Kononec P.V., Shveikin A.O., Shestakov A.L.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2017;(12): 28‑35

DOI: 10.17116/hirurgia20171228-35

Read: 1865 times

Download PDF (RU)
Contact the author
Table of contents

GASTROINTESTINAL STROMAL TUMORS: SURGICAL TREATMENT AND TARGETED THERAPY
GASTROINTESTINAL STROMAL TUMORS: SURGICAL TREATMENT AND TARGETED THERAPY

To cite this article:

Kanner DYu, Kononec PV, Shveikin AO, Shestakov AL. Gastrointestinal stromal tumors: surgical treatment and targeted therapy. Pirogov Russian Journal of Surgery. 2017;(12):28‑35. (In Russ.)
https://doi.org/10.17116/hirurgia20171228-35

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Inte­rventional radiological and endo­scopic technologies in diagnosis and treatment of chro­nic pancreatitis. Piro­gov Russian Journal of Surgery. 2024;(11):84-93
Long-term postoperative outcomes after surgical correction of congenital subaortic stenosis. Piro­gov Russian Journal of Surgery. 2024;(12):60-66
Difficulties in surgical treatment of fixed cardiofundal axial esophageal hiatal hernia. Piro­gov Russian Journal of Surgery. 2024;(12):105-108
Evaluation of the impact of a comprehensive reha­bilitation program on improving nutritional status, psychoemotional signs and adve­rse events in patients with mela­noma after surgical treatment. Piro­gov Russian Journal of Surgery. 2024;(12-2):173-178
Surgical access for thoracic and intrathoracic goiter. Piro­gov Russian Journal of Surgery. 2025;(1):54-61
Opti­mized inte­rdisciplinary approach in the treatment of maxi­llary sinus upper wall fractures in children. Russian Bulletin of Otorhinolaryngology. 2024;(5):29-34
Heavy eye syndrome: clinical mani­festations, diagnosis and treatment. Russian Annals of Ophthalmology. 2024;(5):112-117
Giant peri­cranial sinus with exte­nsive occi­pital calvarium defect. Burdenko's Journal of Neurosurgery. 2024;(6):77-87
Surgical treatment of asce­nding aortic dissection after previous thoracic endo­vascular aortic repair and proximal stent-graft indu­ced new entry. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):682-685
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84
Abstract:

Aim. To improve surgical and complex treatment of patients with gastrointestinal stromal tumors (GIST). Material and methods. Our analysis included 97 GIST patients who were at Petrovsky Russian Research Center of Surgery and Moscow City Oncological Hospital №62 from January 2006 to September 2016. Results. Advisability of surgery for GIST patients was confirmed. We have assessed surgical outcomes, defined the indications for adjuvant targeted therapy depending on GIST prognostic risk and additional factors for unfavorable course of disease. Conclusion. It was concluded that surgical treatment is preferred for patients with resectable GISTs. Adjuvant therapy is indicated in patients with high risk of progression if mutations indicating tumor sensitivity to the drugs are revealed. Adjuvant targeted therapy is not indicated in patients with low and very low risk of progression.

Keywords:

gastrointestinal stromal tumor of digestive tract
surgical treatment
adjuvant targeted therapy
imatinib mesilate
malignant potential of tumor
mutational status of tumor

Authors:

Kanner D.Yu.

Oncology Hospital No. 62, Moscow, Russia

Kononec P.V.

Oncology Hospital No. 62, Moscow, Russia

Shveikin A.O.

Moscow City Cancer Hospital No. 62 of Moscow Healthcare Department, Moscow, Russia

Shestakov A.L.

B.V. Petrovsky National Research Centre of Surgery, Moscow

Close metadata

References:

  1. Kostka R, Gürlich R, Koldová L. Gastrointestinal Stromal Tumors (GIST): A Single Center Experience. Acta Chirurgica Belgica. 2012;112(1):33-39. https://doi.org/10.1080/00015458.2012.11680792
  2. Judson I, Demetri G. Advances in the treatment of gastrointestinal stromal tumours. Annals of Oncology. 2007;18(suppl 10):20-24. https://doi.org/10.1093/annonc/mdm410
  3. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, et al. Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor. New England Journal of Medicine. 2001;344(14):1052-1056. https://doi.org/10.1056/nejm200104053441404
  4. Gold JS, van der Zwan SM, Gönen M, Maki RG, Singer S, Brennan MF, et al. Outcome of Metastatic GIST in the Era before Tyrosine Kinase Inhibitors. Annals of Surgical Oncology. 2007;14(10):3027. https://doi.org/10.1245/s10434-006-9297-0
  5. DeMatteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. The Lancet. 2009;373(9669):1097-1104. https://doi.org/10.1016/s0140-6736(09)60500-6
  6. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2014;25 (suppl 3):21-26. https://doi.org/10.1093/annonc/mdu255
  7. Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Human Pathology. 2002;33(5):459-465. https://doi.org/10.1053/hupa.2002.123545
  8. Hou YY, Lu SH, Zhou Y, Xu JF, Ji Y, Hou J et al. Predictive values of clinical and pathological parameters for malignancy of gastrointestinal stromal tumors. Histol Histopathol. 2009;24(6):737-747. https://doi.org/10.14670/HH-24.737
  9. Wardelmann E, Losen I, Hans V, Neidt I, Speidel N, Bierhoff E, et al. Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of thec-kitprotooncogene is associated with metastatic behavior of gastrointestinal stromal tumors. International Journal of Cancer. 2003;106(6):887-895. https://doi.org/10.1002/ijc.11323
  10. Lasota J, Wozniak A, Kopczynski J, Dansonka-Mieszkowska A, Wasag B, Mitsuhashi T, et al. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases. Laboratory Investigation. 2004;85(2):237-247. https://doi.org/10.1038/labinvest.3700218
  11. Schneider-Stock R, Boltze C, Lasota J, Peters B, Corless CL, Ruemmele P, et al. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clin Cancer Res. 2005;11(2 Pt 1):638-645.
  12. Schurr P. Microsatellite DNA Alterations of Gastrointestinal Stromal Tumors Are Predictive for Outcome. Clinical Cancer Research. 2006;12(17):5151-5157. https://doi.org/10.1158/1078-0432.ccr-05-2083
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.